Navigation Links
State House Passes Bill to Help Consumers Struggling With High Summer Electric Bills
Date:5/2/2008

Legislation would protect Illinois consumers against air conditioning disconnection when temperatures may reach 95 degrees or above

SPRINGFIELD, Ill., May 2 /PRNewswire-USNewswire/ -- AARP today commended the Illinois House of Representatives for its unanimous passage of House Bill 5086, which will increase protections for consumers by preventing utility companies from shutting off cooling service if the temperature is forecasted to reach 95 degrees or above.

HB 5086, sponsored by State Representative Bob Flider (D-Decatur), passed the House unanimously on Thursday. It will now move to the State Senate under the sponsorship of Sen. Mike Jacobs (D-Moline).

The legislation provides cooling disconnection protection to residential customers, for non payment of bills, if the temperature is forecasted to reach 95 degrees or above, on any day when the National Weather Service has predicted that temperature for the following 24 hours; it also prevents disconnection on any day preceding a holiday or weekend when the forecast indicates that a temperature of 95 degrees or above will be reached during the holiday or weekend.

"Consumers need protections from having their electricity shut off during extreme summer weather - for older people to be without air-conditioning in the heat can be fatal," said Bob Gallo, AARP Illinois State Director. "AARP commends Rep. Flider and the House for their commitment to protecting Illinois consumers who might be facing hard times, and we urge the Senate to pass this legislation."

According to the Centers for Disease Control and Prevention excessive heat exposure caused 8,015 deaths in the United States from 1979-2003. These were more deaths than those caused by hurricanes, lighting, tornadoes, floods and earthquakes combined.

Current state law provides protections for customers from having their electric or natural gas service disconnected for non payment during the winter months. Ho
'/>"/>

SOURCE AARP Illinois
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Biomarker Spots Which Lesions Likely to Progress to Prostate Cancer
2. Complications Found in Proposed Prostate Cancer Treatment
3. State Health Secretary Visits City of Chester for Cover the Uninsured Week
4. Canary Foundation and the National Cancer Institute Launch New Prostate Cancer Study
5. Study raises questions about prostate cancer therapies targeting IGF-1
6. American Lung Association Issues State of the Air Report: First City Outside California (Pittsburgh) Tops One of the Most-Polluted Lists
7. Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States
8. BlueCross BlueShield of South Carolina and WellPoint Affiliate Receive State Approval for Ten South Carolina Counties
9. Statement by UHW President Sal Rosselli on SEIU Threat to Sue UHW Leaders
10. More Cowbell! To end ALS, Riders of the Tri-State Trek Cycle 270 Miles - Making Noise and Raising Money!
11. Pelosi Statement on Cover the Uninsured Week
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 1DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 2DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 3Gene Data Tool Advances Prospects for Personalized Medicine 59221 1Gene Data Tool Advances Prospects for Personalized Medicine 59221 2Gene Data Tool Advances Prospects for Personalized Medicine 59221 3Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 1Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 2Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 3